$0.8254
0.022.18%
At close: -
$0.8093
-0.02-1.95%
After Hours: Dec 20, 5:09 PM EDT
RAPT Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of RAPT Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-12 | $-0.47 | $-0.54 | 13.0 % |
Jun 2024 | 2024-08-08 | $-0.71 | $-0.72 | 1.39 % |
Mar 2024 | 2024-05-09 | $-0.79 | $-0.81 | 2.47 % |
Dec 2023 | 2024-03-07 | $-0.80 | $-0.86 | 6.98 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-14 | $0 | $220.00K | -100.0 % |
Sep 2022 | 2022-11-10 | $0 | $340.00K | -100.0 % |
Jun 2022 | 2022-08-11 | $886.00K | $280.00K | 216.4 % |
Mar 2022 | 2022-05-11 | $641.00K | $220.00K | 191.4 % |
RAPT Therapeutics (RAPT) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 12, 2024 for Q3.
The Actual EPS was $-0.47, which beat the estimate of $-0.54.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.